Skip to main content

FutureTech II Acquisition Corp.

FTIIDelisted Jul 11, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001889450

FutureTech II Acquisition Corp. was delisted on Jul 11, 2025; its insiders filed their last Form 4 on Feb 6, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.

Holders of 5% or more of FTII

Holders whose latest Schedule 13D or 13G filing reports 5% or more of FutureTech II Acquisition Corp., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of FTII
HolderLatest formStakeChangeFirst filedLatest filingFiling
Calamos Investment Trust13G/A11.60%496.4K shares−0.10 ppfrom 11.70%Feb 12, 20253 filingsMay 2, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on FutureTech II Acquisition Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on FTII
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20256:37 AM ETWalleye Capital LLC13G/A0.00%0 shares−5.44 ppfrom 5.44%Below 5%Mar 31, 2025SEC
May 14, 20253:30 PM ETHudson Bay Capital Management LPand 1 other13G/A4.65%199.3K shares–Below 5%Mar 31, 2025SEC
May 2, 202511:40 AM ETCalamos Investment Trust13G/A11.60%496.4K shares−0.10 ppfrom 11.70%Apr 30, 2025SEC
Apr 4, 202511:49 AM ETCalamos Investment Trust13G/A11.70%500.0K shares0.00 ppfrom 11.70%Mar 31, 2025SEC
Feb 12, 20254:55 PM ETCalamos Investment Trust13G/A11.70%500.0K shares–Dec 31, 2024SEC
Feb 6, 20252:54 PM ETWalleye Capital LLC13G/A5.44%160.9K shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell FutureTech II Acquisition Corp. shares.

No Form 144 notices for FutureTech II Acquisition Corp. are on file.